Leonardo DRS holds the cleaner structural position, with valuation as the main driver and profitability adding further support. Corcept Therapeutics still has the edge on growth, which keeps the comparison from looking entirely one-sided. The market setup is mixed, without a decisive signal in either direction. The market is not adding a decisive signal either way — the structural read carries the weight.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the Russell 1000 universe, making them directly comparable.
This is not just a one-metric split: both valuation and profitability materially support the lead. The overall score gap is 20 points in favour of Leonardo DRS, Inc..
This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.
A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.
The match is driven mainly by capital structure and operating margin level.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Pricing and operating quality both support the lead here.
Left means cheaper relative valuation. Higher means stronger structure.
Leonardo DRS, Inc. looks stronger both structurally and on relative valuation.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where CORT and DRS each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The multiple-based pricing edge comes from a trailing P/E that is 216 turns lower.
Corcept Therapeutics still pushes back on growth, with a 21.6-point revenue-growth advantage that keeps the read from becoming one-way.
Valuation is the clearest driver of the lead, with profitability adding further support — though growth still provides a real counterweight.
Break down the CORT vs DRS comparison across all dimensions with the full interactive tool.
Explore how CORT and DRS each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.